Does “Japanese Walking” Actually Work?

Interval walking, the thing social media renamed Japanese walking in 2025, does what its original trial says it does: in older adults, alternating fast and slow walking for five months improved leg strength, aerobic capacity and resting blood pressure more than steady walking did. That trial was publicly funded, randomised, and has been cited hundreds of times. It is also nearly twenty years old, its participants averaged 63, and the largest trial to test the method outside a supervised programme found that people mostly stopped doing it.

Both halves matter. The method is real. Whether a screen worker in their thirties will do it four days a week for five months is the question the evidence does not answer.

Where the name came from

Interest in the term Japanese walking rose by 2,968 per cent year on year in one gym chain’s annual analysis of global search data, measured as a three-month rolling average and making it the fastest-growing fitness search of 2026. The name refers to a research programme at Shinshu University in Japan that has been running since the early 2000s, and specifically to one paper.

The original trial

That paper appeared in Mayo Clinic Proceedings in 200761303-7/abstract). Over five months in 2004, 246 healthy, non-smoking adults aged 44 to 78, with a mean age of 63, were randomly divided into three groups: no walking training, moderate-intensity continuous walking, and high-intensity interval walking. The continuous group was asked to walk at roughly half their peak aerobic capacity and to log 8,000 or more steps a day on four or more days a week. The interval group alternated short bouts of fast walking above 70 per cent of peak capacity with bouts of slow walking, using a device that tracked intensity.

The results are the ones that circulate. In the interval group, isometric knee extension strength increased by 13 per cent and knee flexion by 17 per cent, peak aerobic capacity for cycling rose by 8 per cent and for walking by 9 per cent, and all four gains were significantly larger than in the continuous walking group. The reduction in resting systolic blood pressure was also greater in the interval group. The authors’ conclusion is measured: high-intensity interval walking may protect against age-associated increases in blood pressure and decreases in thigh muscle strength and peak aerobic capacity.

An accompanying editorial by an American obesity researcher supplied the line that has been quoted since: we are designed to walk all day long, and the paper suggests that we should.

Funding was public: grants from Japan’s Ministry of Health, Labour and Welfare, the Japan Society for the Promotion of Science, and the Ministry of Economy, Trade and Industry. No industry funding is declared, which is unusual enough in fitness research to be worth stating.

What the trial does not tell a desk worker

Three limits sit inside the abstract.

The population. Everyone was 44 or older, averaging 63, and the paper’s framing is about protecting against age-associated decline. Effects on thigh strength and aerobic capacity in people who are already losing both with age are not automatically the effects in a 32-year-old whose main problem is nine hours of sitting. No trial in this literature has tested the method in working-age office workers.

The targets. The abstract reports how many participants actually met their training targets: in the interval group, 11 of 19 men and 31 of 68 women. That is under half, in a supervised university programme with monthly check-ins. The reported gains are for the group as assigned, which is the right analysis, but it means the average person in the interval arm did less than the headline protocol.

The comparison. The interval group’s total walking time was only 83 per cent of the continuous group’s, and the continuous group was itself walking at a moderate pace most days. The trial shows that intensity beat volume for these outcomes. It does not show that thirty minutes of intervals beats doing nothing much, because doing nothing much is what the third group did and that group is the comparison nobody quotes. This is the same distinction this site drew on whether you need 10,000 steps: step volume and intensity answer different questions.

The trial that tested it in the wild

The Shinshu group has reported very high adherence within its own programme, quoting a 94 per cent rate against around 60 per cent for standard walking training. The test of that claim is what happens when the method leaves the programme.

A Danish randomised trial published in 2022 did exactly that. It enrolled 214 people with type 2 diabetes referred to municipal lifestyle programmes and randomised them, 140 to interval walking guided by a smartphone app and 74 to the standard exercise programme, for 12 supervised weeks. Afterwards the interval group was encouraged to keep going with the app, three times a week, to 52 weeks. The primary outcome was objectively measured moderate-to-vigorous physical activity, from accelerometers, at one year.

The result: app-based interval walking did not increase objectively measured moderate-to-vigorous activity over 52 weeks compared with standard care, and no differences were observed between the groups. Physical quality of life did improve in the interval group. The authors’ explanation is direct: adherence was low across the 52 weeks, which largely explains the missing effect. During the supervised 12 weeks adherence was remarkably higher and activity rose. The decline came when supervision was subtracted, which the authors note is in line with previous studies. No conflicts of interest were declared.

The same group published a qualitative study whose title is a participant quote: “I tried forcing myself to do it, but then it becomes a boring chore.”

That is a diabetes population, not a healthy one, and an app rather than a coach. But it is the only long randomised test of the method as most people will actually encounter it, unsupervised and self-scheduled, and its finding is that the walking was not the problem. Keeping it up was.

What this means for you

This article prescribes no protocol, because the sources tested a specific supervised programme in specific populations and this site does not turn a trial’s design into an instruction.

What the evidence does support is narrower and still useful. Adding some intensity to walking produces fitness and blood pressure changes that steady walking at the same or greater volume does not, at least in older adults. Those changes are the kind that matter for a sedentary job, and they are adjacent to what this site found on exercise as a treatment for depression, where the walking evidence was the least uncertain. And how often to get up from sitting is a separate question that intervals do not answer.

If you have high blood pressure, a heart condition, or take medication that affects heart rate, high-intensity effort of any kind is a conversation with a doctor before it is a habit. The original trial excluded anyone with cardiovascular or pulmonary disease, which means its safety record does not extend to people who have either.

Common questions

What is Japanese walking?

It is the social media name for interval walking training, a method from Shinshu University in Japan that alternates bouts of fast walking at high intensity with bouts of slow walking. The name took off in 2025 and the term rose 2,968 per cent in one global search analysis for 2026. The underlying research dates to a 2007 randomised trial in Mayo Clinic Proceedings.

Does it work better than normal walking?

In the 2007 trial of 246 adults aged 44 to 78, yes on the outcomes measured: knee extension strength rose 13 per cent and flexion 17 per cent, peak aerobic capacity rose 8 to 9 per cent, and resting systolic blood pressure fell more, all significantly greater than in a group walking continuously at moderate intensity. The interval group walked for less total time. Fewer than half of participants met their training targets, and the trial has not been repeated in working-age adults.

Will I actually stick with it?

That is the open question, and the best evidence is not encouraging. A 2022 Danish randomised trial of 214 people with type 2 diabetes found app-guided interval walking did not increase objectively measured activity over 52 weeks compared with standard care, because adherence fell once the 12 supervised weeks ended. The originating group reports 94 per cent adherence inside its own programme. The difference appears to be supervision, not the method.

Is it safe if I have high blood pressure?

The original trial excluded people with cardiovascular or pulmonary disease, so its safety findings do not cover them. Anyone with high blood pressure, a heart condition, or medication affecting heart rate should discuss high-intensity exercise with a doctor before starting. This article does not prescribe intensities, durations or frequencies.

A real method with a real catch

It is rare for a viral fitness trend to trace back to a publicly funded randomised trial with a measured conclusion, and this one does. The method works, on the outcomes measured, in the people measured.

The catch is not in the physiology. It is that the one trial to release the method into ordinary life without a coach watched most people drift away from it within the year. The interesting question is not whether interval walking beats steady walking. It is what makes a person keep doing either, and that is a question the walking trials were not designed to answer.